Publication:
MICA*A4 protects against ulcerative colitis, whereas MICA*A5.1 is associated with abscess formation and age of onset.

dc.contributor.authorMartinez-Chamorro, A
dc.contributor.authorMoreno, A
dc.contributor.authorGómez-García, M
dc.contributor.authorCabello, M J
dc.contributor.authorMartin, J
dc.contributor.authorLopez-Nevot, M Á
dc.date.accessioned2023-01-25T08:31:14Z
dc.date.available2023-01-25T08:31:14Z
dc.date.issued2016-04-05
dc.description.abstractUlcerative colitis (UC) is one of the two major forms of inflammatory bowel disease, the aetiology of which remains unknown. Several studies have demonstrated the genetic basis of disease, identifying more than 130 susceptibility loci. The major histocompatibility complex class I chain-related gene A (MICA) is a useful candidate to be involved in UC pathogenesis, because it could be important in recognizing the integrity of the epithelial cell and its response to stress. The aim of this study was to analyse the relationship between polymorphisms in the transmembrane domain of MICA and susceptibility to develop UC. A total of 340 patients with UC and 636 healthy controls were genotyped for MICA transmembrane polymorphism using a polymerase chain reaction (PCR) combined with fluorescent technology. Different MICA alleles were determined depending on the PCR product size. The allele MICA*A4 was less frequent in patients than in controls (P = 0·003; OR = 0·643), and this protective role is higher when it forms haplotype with B*27 (P = 0·002; OR = 0·294). The haplotype HLA-B*52/MICA*A6 was also associated with UC [P = 0·001; odds ratio (OR) = 2·914]. No other alleles, genotypes or haplotypes were related with UC risk. Moreover, MICA*A5.1 is associated independently with abscesses (P = 0·002; OR = 3·096) and its frequency is lower in patients diagnosed between ages 17 and 40 years (P = 0·007; OR = 0·633), meaning an extreme age on onset. No association with location, extra-intestinal manifestations or need for surgery was found.
dc.identifier.doi10.1111/cei.12786
dc.identifier.essn1365-2249
dc.identifier.pmcPMC4872378
dc.identifier.pmid26940143
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872378/pdf
dc.identifier.unpaywallURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872378
dc.identifier.urihttp://hdl.handle.net/10668/9891
dc.issue.number3
dc.journal.titleClinical and experimental immunology
dc.journal.titleabbreviationClin Exp Immunol
dc.language.isoen
dc.organizationHospital Universitario Virgen de las Nieves
dc.page.number323-31
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subjectMHC
dc.subjectautoimmunity
dc.subjectcell surface molecules
dc.subjectinflammation
dc.subjectmolecular biology
dc.subject.meshAbscess
dc.subject.meshAdult
dc.subject.meshAge of Onset
dc.subject.meshAlleles
dc.subject.meshAmino Acid Sequence
dc.subject.meshCase-Control Studies
dc.subject.meshColitis, Ulcerative
dc.subject.meshFemale
dc.subject.meshGene Expression
dc.subject.meshGene Frequency
dc.subject.meshGenetic Predisposition to Disease
dc.subject.meshHLA-B27 Antigen
dc.subject.meshHLA-B52 Antigen
dc.subject.meshHaplotypes
dc.subject.meshHistocompatibility Antigens Class I
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshModels, Molecular
dc.subject.meshOdds Ratio
dc.subject.meshPolymorphism, Genetic
dc.subject.meshProtein Domains
dc.subject.meshProtein Isoforms
dc.subject.meshSequence Alignment
dc.titleMICA*A4 protects against ulcerative colitis, whereas MICA*A5.1 is associated with abscess formation and age of onset.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number184
dspace.entity.typePublication

Files